FeaturedNeuroscienceOpen Neuroscience Articles·April 6, 2020·5 min readA new antiviral drug heading into clinical trials offers hope for COVID-19EIDD-2801, a new antiviral drug, has the potential to treat coronavirus. A new study reveals the drug can prevent severe lung injury in mouse models and cultured human lung cells infected with COVID-19. The drug will soon be ready for human testing.Read More
